Infinity Natural Resources launches IPO

Infinity Natural valued at $1.3 billion in debut as US energy IPOs rebound
Infinity Natural Resources was valued at $1.30 billion after its shares jumped nearly 11% in their NYSE debut on Friday, underscoring a rebound in energy listings against the backdrop of a more fossil fuel-friendly Trump administration.
IPOs from Infinity Natural Resources and Beta Bionics rise despite market swoon
Oil company Natural Resources and medical-device maker Beta Bionics shrug off a down market to gain in their trading debuts.
Infinity Natural Resources launches IPO, starts trading 11% higher
Infinity Natural Resources, an independent energy company, has launched its initial public offering (IPO) today. The company priced 13,250,000 shares of its Class A common stock at $20.00 each. Trading commenced on the New York Stock Exchange (NYSE) under the ticker symbol "INR",
Opening Day: Infinity Natural Resources valued at $1.3B in market debut
Shares of Infinity Natural Resources jumped almost 11% in their NYSE debut, valuing the oil and natural gas producer at $1.3B. The listing
Oil company Infinity Natural Resources debuts IPO amid deregulation push
Infinity Natural Resources Inc. priced its initial public offering above the midpoint of its range in a sign of a strong stock-market debut for the oil and gas producer, which operates in Ohio and Pennsylvania.
Pearl Energy-backed Infinity Natural Resources raises $265 mln in US IPO
Private equity-backed oil and natural gas producer Infinity Natural Resources on Thursday raised $265 million in its initial public offering in the United States.
Weight-loss drug developer Metsera targets up to $1.78 billion valuation in US IPO
Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.
Unilever considering IPO of ice cream business in the US - Bloomberg
Unilever Plc (NYSE:UL) is evaluating an initial public offering of its ice cream business in the U.S. The company is also ...
US Pork Giant Smithfield Foods Raises $522M After Pricing IPO Below Range
Smithfield Foods and its Chinese parent raised around $522 million from the U.S. pork giant's initial public offering after ...
Cement producer Titan America targets up to $3.3 billion valuation in US IPO
(Reuters) -Belgium-based Titan America is seeking a valuation of up to $3.32 billion in its New York listing, as the initial ...
WBEZ12h
White activists sue Bally’s over Chicago casino IPO limited to women, minorities
Bally's announced a $250 million public offering last month for shares of its massive Chicago casino project, but only to ...
Karman Holdings Aims High With $100 Million US IPO Plan
Learn about Karman Holdings' upcoming $100 million US IPO, their focus on missile and space systems, and the financial ...
Titan America Sets IPO Terms That Could Push Market Cap Above $3 Billion
Titan America, which makes heavy building materials and operates primarily on the U.S. Eastern Seaboard, on Tuesday said it plans to sell 9 million shares at between $15 and $18 apiece in the IPO, for ...
J&J-Backed Medtech Firm HistoSonics Considers US IPO
HistoSonics Inc., a medical device company whose backers include Johnson & Johnson’s venture capital arm, is weighing a US ...
ETF Daily News2d
Titan America SA Plans $396 Million IPO for February 7th (TTAM)
Titan America SA (TTAM) expects to raise $396 million in an initial public offering (IPO) on Friday, February 7th, IPO Scoop reports. The company will be issuing 24,000,000 shares at a price of ...
Techopedia3d
Crypto IPO Boom in 2025: 5 Major Listings to Expect
Falling interest rates and crypto-friendly regulations are stirring talks of a crypto IPO boom. Explore the top crypto IPOs ...
Cement Producer Titan America Seeks up to $3.3 Billion Valuation in US IPO
(Reuters) - Titan America is seeking a valuation of up to $3.32 billion in its New York initial public offering, the ...
Biocon Biologics plans IPO for biosimilars business by Mar 2026: CEO
The company, which has been pushing its IPO plans for the past year, has been waiting to complete the integration of its acquired biosimilars firm Viatris and refinance debt before it goes public ...